Site Search

Other ...

Navigation

Other ...

Help & FAQs

Other The new Alzforum has launched, and we couldn’t be more excited!  To prepare for this event, we took the time to anticipate a few questions you might have. Do I have to do anything differently to get to the website? No. Alzforum will still be at the same U

About the Team

Other Gabrielle Strobel, Executive Editor Gabrielle Strobel oversees Alzforum's editorial operations, including research and conference reporting, expert commentary, and webinar discussions. She initiated the AlzBiomarkers database and curates the Therapeu

Q&A with Richard Bozanich

Other Questions by Gabrielle Strobel Richard Bozanich, 50, has early onset dementia, Probable Alzheimer's Type. During his career, Bozanich was a journalist who wrote and/or edited for the Harvard Business School, the Los Angeles Times, the Dallas Morning

Interview: One Man's Forward Approach

Other Thomas Greene's mother developed AD in her mid-thirties. Thomas decided to end uncertainty about his own genetic status and took a predictive test when he was 31. When it came back positive for an AD mutation, he grabbed the bull by its horns as best

Interview with Jennifer Williamson

Other By Gabrielle Strobel Jennifer Williamson is a genetic counselor at the Taub Institute for Research on Alzheimer's Disease and the Aging Brain and the Gertrude H. Sergievsky Center at Columbia University, New York. She sees families with neurogenetic

NPR Audio Interviews with Thomas Debaggio

Other When he was 55, herb farmer Tom DeBaggio, called the "Best Rosemaryologist in the country," began to notice problems with his memory. Working the checkout register of his family business, he could not name plants he'd been growing for decad

Where to Turn for Research: Human Studies of eFAD

Other By Gabrielle Strobel Editor's note:  For definitions of early onset Alzheimer disease (EOAD) and early onset familial Alzheimer disease (eFAD), please see our essay, What Is Early Onset Familial Alzheimer Disease (eFAD)? Families with eFAD who are wi

Prevention With Statins: Can the Brain Learn From the Heart?

Other By Gabrielle Strobel Cholesterol-lowering statin drugs give people with high blood cholesterol a fair shot at averting a future heart attack. Patients and their doctors across the country got to this place through a 20-year-long series of treatment and pr

Devil in the Details—The Challenges of Prevention Trials

Other By Gabrielle Strobel Companies have not yet tried to repeat the statin story in Alzheimer disease. You cannot simply make a carbon copy of a successful drug development strategy, they say, and once you start thinking about the particulars of AD, tricky pr

Prevention—Do eFAD Families Hold the Key?

Other By Gabrielle Strobel Editor's note:  For definitions of early onset familial Alzheimer disease (eFAD), early onset AD (EOAD), and late-onset AD (LOAD), please visit  What Is Early Onset Familial Alzheimer Disease. Historically, people with early onse

Interview: A Spouse's Perspective on Clinical Trials for eFAD

Other In this conversation with Gabrielle Strobel, the husband of a 39-year-old woman with early onset familial AD (eFAD) discusses the uncharted territory of clinical trials for eFAD patients. All names are pseudonyms. See our previous interview with this coup

Drug Trials in Early Onset AD

Other By Gabrielle Strobel In the world of drug testing, there are a number of different avenues by which people with eFAD and EOAD could contribute to the goal of therapy development and in the process hope to obtain access to up-to-date care. Each has its pro

Clinical Trials: Why Are eFAD Patients Excluded? Will That Change?

Other By Gabrielle Strobel Families with early\ onset Alzheimer disease (eFAD) are an isolated group dispersed all over the world. See  Interview: A Spouse's Perspective on Clinical Trials for eFAD. Part of their problem is that they are excluded from part